Loading...
Daicel Corporation
DACHF•PNK
Basic Materials
Chemicals - Specialty
$8.43
$0.00(0.00%)
Daicel Corporation (DACHF) Financial Performance & Income Statement Overview
Review Daicel Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.10%
↑ 5.10%
Operating Income Growth
-2.21%
↓ 2.21%
Net Income Growth
-11.38%
↓ 11.38%
Operating Cash Flow Growth
21.73%
↑ 21.73%
Operating Margin
10.40%
↑ 10.40%
Gross Margin
28.09%
↑ 28.09%
Net Profit Margin
8.44%
↑ 8.44%
ROE
13.18%
↑ 13.18%
ROIC
10.11%
↑ 10.11%
Daicel Corporation (DACHF) Income Statement & Financial Overview
Review Daicel Corporation's (DACHF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $153.99B | $142.86B | $144.12B | $145.57B |
| Cost of Revenue | $110.36B | $105.74B | $103.65B | $102.04B |
| Gross Profit | $43.62B | $37.12B | $40.47B | $43.53B |
| Gross Profit Ratio | $0.28 | $0.26 | $0.28 | $0.30 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $25.86B | $25.48B | $26.32B | $26.07B |
| Operating Expenses | $25.86B | $25.48B | $26.32B | $26.08B |
| Total Costs & Expenses | $136.22B | $131.22B | $129.97B | $128.11B |
| Interest Income | $293.00M | $286.00M | $330.00M | $296.00M |
| Interest Expense | $635.00M | $0.00 | $401.00M | $398.00M |
| Depreciation & Amortization | $11.16B | $10.50B | $9.86B | -$17.46B |
| EBITDA | $20.19B | $22.14B | $24.003B | $4.62B |
| EBITDA Ratio | $0.13 | $0.15 | $0.17 | $0.03 |
| Operating Income | $17.77B | $11.64B | $14.15B | $17.46B |
| Operating Income Ratio | $0.12 | $0.08 | $0.10 | $0.12 |
| Other Income/Expenses (Net) | -$9.57B | $3.89B | $5.94B | $4.22B |
| Income Before Tax | $8.20B | $15.53B | $20.09B | $21.68B |
| Income Before Tax Ratio | $0.05 | $0.11 | $0.14 | $0.15 |
| Income Tax Expense | $2.40B | $3.44B | $3.96B | $5.23B |
| Net Income | $5.44B | $11.99B | $15.86B | $16.19B |
| Net Income Ratio | $0.04 | $0.08 | $0.11 | $0.11 |
| EPS | $20.40 | $44.00 | $57.48 | $58.70 |
| Diluted EPS | $20.40 | $44.00 | $57.48 | $58.70 |
| Weighted Avg Shares Outstanding | $266.56M | $272.48M | $275.97M | $275.81M |
| Weighted Avg Shares Outstanding (Diluted) | $266.56M | $272.48M | $275.97M | $275.81M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan